Alpha 2.0
Login Register
» Authors » Nele Kanzelmeyer

Nele Kanzelmeyer

Explore the profile of Nele Kanzelmeyer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 96
Followers 0
Related Specialties
Pediatrics
Nephrology
Biochemistry
Top 10 Co-Authors
Lars Pape
Dieter Haffner
Burkhard Tonshoff
Thomas Lucke
Markus J Kemper
Anibh M Das
Jun Oh
Anette Melk
Dimitrios Tsikas
Lutz T Weber
Published In
Pediatr Nephrol
Amino Acids
Pediatr Transplant
J Inherit Metab Dis
Kidney Int Rep
Affiliations
Soon will be listed here.
Recent Articles
11.
Favorable Outcome After Single-kidney Transplantation From Small Donors in Children: A Match-controlled CERTAIN Registry Study
Schild R, Carvajal Abreu K, Buscher A, Kanzelmeyer N, Lezius S, Krupka K, et al.
Transplantation . 2024 Apr; 108(8):1793-1801. PMID: 38685197
Background: Kidney transplantation (KTx) from small donors is associated with inferior graft survival in registry studies, whereas single-center studies show favorable results. Methods: We compared 175 pediatric KTx from small...
12.
Physical activity and its impact on cardiovascular health in pediatric kidney transplant recipients
Kohlmeier L, von der Born J, Lehmann E, Frode K, Grabitz C, Greiner A, et al.
Pediatr Nephrol . 2023 Dec; 39(5):1587-1598. PMID: 38103064
Background: Cardiovascular (CV) morbidity after kidney transplantation (KTx) in childhood is of increasing importance. In light of a high prevalence of CV risk factors, protective measures such as physical activity...
13.
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Tietze H, Pott V, Kanzelmeyer N, Memaran N, Baumann U, Mindermann C, et al.
Osteoporos Int . 2023 Nov; 35(3):533-542. PMID: 37940696
Purpose: Soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) are regulators of osteoclast differentiation and activation and thus bone metabolic turnover in children. Adequate pediatric...
14.
LMS-Based Pediatric Reference Values for Parameters of Phosphate Homeostasis in the HARP Cohort
Pott V, Tietze H, Kanzelmeyer N, von der Born J, Baumann U, Mindermann C, et al.
J Clin Endocrinol Metab . 2023 Oct; 109(3):668-679. PMID: 37850343
Context: The assessment of phosphate homeostasis in children is challenging due to the marked changes in laboratory parameters during growth and development, and the lack of adequate reference values. Objective:...
15.
Cerebral microstructural changes in children suffering from hemolytic uremic syndrome
Bultmann E, Zapf A, Mussgnug H, Kanzelmeyer N, Hartmann H
Eur J Pediatr . 2023 Aug; 182(10):4663-4672. PMID: 37558834
To evaluate microstructural cerebral changes in children suffering from typical hemolytic uremic syndrome (HUS) based on apparent diffusion coefficient (ADC) maps. For 12 pediatric HUS patients (0.8 - 14.6 years...
16.
The significance of central blood pressure for cardiovascular target organ damage in children and adolescents after kidney transplantation
Greiner A, von der Born J, Kohlmeier L, Grabitz C, Bauer E, Memaran N, et al.
Pediatr Nephrol . 2023 Jan; 38(8):2791-2799. PMID: 36629915
Background: Cardiovascular (CV) complications are important causes of morbidity and mortality in children after kidney transplantation (KTx). In adults, central blood pressure (cBP) is an accepted predictor of CV sequelae....
17.
Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study
Veys K, Zadora W, Hohenfellner K, Bockenhauer D, Janssen M, Niaudet P, et al.
J Inherit Metab Dis . 2022 Sep; 46(1):43-54. PMID: 36117148
Infantile nephropathic cystinosis (INC) is an inheritable lysosomal storage disorder characterized by lysosomal cystine accumulation, progressive kidney disease, and multiple extrarenal complications (ERCs). Cysteamine postpones the onset of end-stage kidney...
18.
Safety of Therapeutic Apheresis in Children and Adolescents
Taylan C, Schaaf A, Dorn C, Peter Schmitt C, Loos S, Kanzelmeyer N, et al.
Front Pediatr . 2022 May; 10:850819. PMID: 35498796
Background: Therapeutic apheresis (TA) is based on the principles of either removing dissolved pathogenic substances (e.g., antibodies) from the blood plasma or replacing plasma factors. It expands the therapeutic scope...
19.
Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities
Kluck R, Muller S, Jagodzinski C, Hohenfellner K, Buscher A, Kemper M, et al.
J Inherit Metab Dis . 2022 Jan; 45(2):192-202. PMID: 34989402
Children with infantile nephropathic cystinosis (INC), an inherited lysosomal storage disease resulting in cystine accumulation in all body cells, are prone to progressive chronic kidney disease (CKD), impaired growth and...
20.
Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients
Zierhut H, Kanzelmeyer N, Buescher A, Hocker B, Mauz-Korholz C, Tonshoff B, et al.
Pediatr Transplant . 2021 May; 25(6):e14042. PMID: 34021949
Background: Post-transplant lymphoproliferative disease (PTLD) is a life-threatening complication in renal transplant recipients. Immunomodulatory and chemotherapeutic treatment potentially affect allograft function. The aim of this study was to evaluate graft...